Project Bioshield Act

May 11, 2020

Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine

Feb 13, 2020

FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning

Jan 12, 2019

BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

Oct 15, 2018

Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns

Sep 04, 2018

Soligenix Announces Publication of Positive Long-Term Data Supporting Thermostability and Conformational Integrity of the RiVax® Ricin Toxin Vaccine

Aug 07, 2018

Global Biodefense Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.5% - ResearchAndMarkets.com

May 11, 2018

Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results

Jan 25, 2018

Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials

Dec 21, 2017

Soligenix Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule

Aug 14, 2017

Soligenix Receives $2.5M in Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine

Jun 21, 2017

Soligenix Receives Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine